TrialReader


Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study

NCT03405909 — Completed, 517 participants, University Hospital Erlangen

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Standardized Contrast-enhanced Ultrasound (CEUS) -Algorithms for the Non-invasive Diagnosis of Hepatocellular Carcinoma (HCC) in High-risk-patients - a Prospective German Multicenter Study

RegistryNCT03405909, acronym ESCULAP
StatusCompleted
Study typeObservational
Enrollment517 (Actual)
SponsorUniversity Hospital Erlangen (Other)
ConditionsHepatocellular Carcinoma, Cholangiocarcinoma, Intrahepatic, Liver Cirrhosis, Liver Cancer, Liver Neoplasms, Liver Diseases
Interventionscontrast enhanced ultrasound (CEUS), MRI, Histology (Diagnostic test)
Datesstart 2018-04-21, primary completion 2019-04-06, completion 2019-04-06, first posted 2018-01-23, last updated 2021-03-02
Locations1 site in Germany

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Hepatocellular Carcinoma All trials for Cholangiocarcinoma, Intrahepatic All trials of contrast enhanced ultrasound (CEUS) All trials of MRI

-Summary

Aim of this prospective national multicenter study is to improve standardization of contrast-enhanced ultrasound (CEUS) in the non-invasive diagnosis of hepatocellular carcinoma (HCC) in high-risk patients.

The study is funded by the German Society for Ultrasound in Medicine (DEGUM).

Expand all sections  ·  Collapse all

+Detailed description

To date, CEUS criteria for non-invasive diagnosis of HCC include arterial phase hyperenhancement, followed by contrast washout in the portal venous or late phase. We would like to investigate the following points:

1. whether arterial hyperenhancement alone is sufficient for the definite diagnosis of HCC in cirrhosis with CEUS
2. whether a further clearly-defined point of assessment in the late phase after 4-6 minutes is of additional diagnostic value in focal liver lesions showing no contrast washout after 3 minutes
3. diagnostic value of CEUS-based standardised diagnostic algorithms (ESCULAP = Erlanger Synopsis of Contrast Enhanced Ultrasound for Liver lesion Assessment in Patients at risk; CEUS LI-RADS = Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System) for non-invasive diagnosis of HCC in high-risk patients (diagnostic accuracy, interobserver-variability, feasability in clinical Routine).

+Arms and interventions

ArmTypeInterventionsDescription
Patients at risk for HCCDiagnostic Test: contrast enhanced ultrasound (CEUS); Diagnostic Test: MRI; Diagnostic Test: HistologyPatients with any of the following conditions: liver cirrhosis of any origin chronic hepatitis B infection chronic hepatitis C infection with advanced fibrosis non-alcoholic steatohepatitis (NASH) hemochromatosis Interventions: B-mode ultrasound, contrast enhanced ultrasound (CEUS); MRI / histology
  • contrast enhanced ultrasound (CEUS) (Diagnostic test): CEUS with SonoVue following standardized protocol
  • MRI (Diagnostic test): CE-MRI following standardized protocol
  • Histology (Diagnostic test): diagnostic liver biopsy

+Outcome measures

Primary outcomes

  • Diagnostic value of standardised CEUS-based algorithms for the non-invasive diagnosis of HCC in high-risk patients [2 years]: Diagnostic accuracy, interobserver-variabilty and feasability in clinical routine for CEUS-based algorithms Reference Standard: histology / MRI

Secondary outcomes

  • Diagnostic value / dispensability of contrast washout for definite diagnosis of HCC with CEUS [2 years]: Sensitvity, specificity, positive and negative predictive value of arterial hyperenhancement only compared with arterial hyperenhancement followed by contrast washout for non-invasive diagnosis of HCC in high-risk patients Reference Standard: histology / MRI
  • Standardisation of CEUS examinations [2 years]: Diagnostic value of an additional standardised examination point in the late phase after 4-6 minutes in lesions without contrast washout after 3 minutes Reference Standard: histology / MRI
  • Diagnostic accuracy of CEUS in intrahepatic cholangiocellular carcinoma (ICC) [2 years]: Sensitvity, specificity, positive and negative predictive value of contrast-enhanced ultrasound for non-invasive diagnosis of ICC in high-risk patients / differential diagnosis of HCC versus ICC Reference Standard: histology
  • Comparison of two CEUS-based algorithms [2 years]: ESCULAP versus CEUS LI-RADS (diagnostic accuracy, interobserver agreement) Reference Standard: histology / MRI
  • Non-inferiority of CEUS versus MRI for non-invasive diagnosis of HCC [2 years]: Comparison of CEUS and MRI for non-invasive diagnosis of HCC (diagnostic accuracy, interobserver agreement) Reference Standard: histology
  • Influence of histological grading on contrast enhancement behaviour [2 years]: correlation of histological grading and contrast enhancement pattern

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* high risk for HCC
* focal liver lesion on B-mode ultrasound

Exclusion Criteria:

* pre-treated HCC lesion
* systemic therapy for HCC (sorafenib, regorafenib and others)

+Locations (1)

FacilityCityCountryStatus
University Hospital Erlangen, Department of Medicine 1Erlangen, BavariaGermany

+Investigators

  • Barbara Schellhaas, MD, Principal investigator, University Hospital Erlangen, Department of Medicine 1
  • Deike Strobel, MD, Principal investigator, University Hospital Erlangen, Department of Medicine 1

My Notes